abs274.txt	clinically	relevant	subtypes	exist	for	pancreatic	ductal	adenocarcinoma	(pdac)	but	molecular	characterization	is	not	yet	standard	in	clinical	care		weimplemented	a	biopsy	protocol	to	perform	time-sensitive	whole-exome	sequencingand	rna	sequencing	patients	with	advanced	pdac	therapeutically	relevantgenomic	alterations	were	identified	48%	(34/71)	and	pathogenic/likelypathogenic	germline	18%	(13/71)	of	overall	30%	(21/71)of	enrolled	experienced	change	management	as	result	ofgenomic	data	twenty-six	had	and/or	somatic	indna-damage	repair	genes	5	additional	mutational	signatures	ofhomologous	recombination	deficiency	no	causal	genomic	alteration	two	oncogenic	in-frame	braf	deletions	we	report	the	firstclinical	evidence	that	this	confers	sensitivity	mapk	pathwayinhibition	moreover	tumor/stroma	gene	expression	withclinical	relevance	collectively	these	demonstrate	feasibility	andvalue	real-time	significance	analyses	metastatic	tumors	are	challenging	due	theheterogeneous	cellular	composition	specimens	rapid	progression	ofthe	disease	using	an	integrated	multidisciplinary	program	demonstratethat	can	identify	clinicallyrelevant	inform	difficult	cancerdiscov	8(9)	1096-111	Â©2018	aacr	see	related	commentary	by	collisson	p	1062this	article	highlighted	issue	feature	1047
